Business Context and Reporting Period
This Form 8-K Current Report was filed by iBio, Inc. on July 24, 2017. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities with Lincoln Park Capital Fund, LLC ("LPCF").
Key Financial Metrics and Transaction Details
- Agreement Type: Common Stock Purchase Agreement and Registration Rights Agreement.
- Total Facility Size: Up to $16.0 million in common stock over a 36-month term.
- Initial Sale: 2,500,000 newly issued shares sold at $0.40 per share for $1.0 million in cash.
- Remaining Availability: Up to $15.0 million subject to future purchases at the Company's option.
- Commitment Fee: 3% of the total availability ($480,000 value), paid via the issuance of 1.2 million shares valued at $0.40 per share.
- Use of Proceeds: Working capital and general corporate purposes.
- Financial Metrics: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period.
Material Changes and Pricing Mechanics
The Company established a new financing mechanism allowing for flexible capital raises. Key pricing and structural terms include:
- Pricing Formula: The purchase price per share is the lower of (i) the lowest sale price on the purchase date or (ii) the arithmetic average of the three lowest closing sale prices during the ten consecutive business days preceding the purchase date.
- Price Floor: Purchases may only occur if the closing price exceeds $0.25 per share.
- Ownership Cap: Sales are restricted if they would cause LPCF to beneficially own more than 9.99% of the Company's common stock.
- Termination: The Company may terminate the agreement at any time without penalty. The agreement automatically terminates in the event of bankruptcy proceedings.
Outlook, Risks, and Management Commentary
- Management Discretion: Actual sales depend on market conditions, trading prices, and the Company's determination of funding needs. LPCF has no right to require sales but is obligated to purchase when directed.
- Risk Factors: The agreement includes an "event of default" clause where the Company cannot initiate purchases until cured. There are no trading volume restrictions or upper price limits for LPCF.
- Investor Restrictions: LPCF has covenanted not to engage in short selling or hedging of the Company's shares.
- Regulatory Status: Securities were sold under Section 4(a)(2) and Regulation D exemptions. A registration statement is to be filed for future sales.
Investor Verification Checklist
- Verify the current share price relative to the $0.25 minimum threshold required to trigger purchases.
- Confirm the dilution impact of the initial 2.5 million shares and the 1.2 million commitment fee shares issued.
- Review the full text of the Purchase Agreement (Exhibit 10.1) for specific "event of default" definitions.
- Monitor the filing of the registration statement required to enable future sales under the agreement.
- Assess the Company's cash burn rate to determine the likelihood of utilizing the remaining $15.0 million facility.